CHI Advisors LLC - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 50 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHI Advisors LLC ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$458,000
-78.5%
200,000
-91.5%
0.14%
-75.4%
Q1 2023$2,128,856
+5.0%
2,339,402
-1.9%
0.56%
+4.6%
Q4 2022$2,026,742
+3.8%
2,384,4020.0%0.54%
+2.9%
Q3 2022$1,952,000
-10.9%
2,384,402
+7.7%
0.52%
-37.3%
Q2 2022$2,192,000
-21.5%
2,214,184
+30.0%
0.84%
-29.5%
Q1 2022$2,793,000
+189.7%
1,703,137
+325.8%
1.19%
+271.2%
Q4 2021$964,000
+20.0%
400,000
+141.1%
0.32%
+36.8%
Q3 2021$803,000
-58.2%
165,927
-76.9%
0.23%
-47.7%
Q2 2021$1,920,000
-8.2%
719,132
+5.9%
0.45%
+6.7%
Q1 2021$2,092,000
+19.7%
679,132
+38.4%
0.42%
-14.8%
Q4 2020$1,748,000
-25.3%
490,877
-15.8%
0.49%
-40.9%
Q3 2020$2,339,000
+136.3%
583,232
+60.2%
0.83%
+115.5%
Q2 2020$990,000
+28.9%
364,1320.0%0.39%
-78.7%
Q1 2020$768,000
-61.9%
364,132
-1.7%
1.81%
+19.2%
Q4 2019$2,014,000
+71.4%
370,307
-5.1%
1.52%
+32.8%
Q3 2019$1,175,000390,3071.14%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$28,105,0004.42%
Novo Holdings A/S 4,420,516$37,928,0003.01%
BVF INC/IL 1,890,507$16,221,0001.42%
Orbimed Advisors 5,967,584$51,202,0000.62%
COWEN INC. 588,706$5,051,0000.46%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 108,000$710,0000.34%
SPHERA FUNDS MANAGEMENT LTD. 321,430$2,758,0000.32%
EcoR1 Capital, LLC 351,401$3,015,0000.27%
Rock Springs Capital Management LP 575,000$4,934,0000.18%
Hikari Power Ltd 32,090$275,0000.03%
View complete list of CORVUS PHARMACEUTICALS INC shareholders